You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Telemetric Microsensor for Glaucoma

    SBC: H-CUBED            Topic: NEI

    PROJECT SUMMARY Glaucoma is an optic nerve disease in which there is progressive loss of retinal ganglion cells leading to irreversible loss of vision. It is estimated to affect 2% of the general population. More than 2.3 million Americans are affected with glaucoma and it is estimated to account for nearly $3B in direct medical costs. It is estimated that 4% of Caucasian patients and 8% of Africa ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  2. Targeting neurotoxic alpha-synuclein aggregates for Parkinson's disease therapy.

    SBC: Vova Ida, LLC            Topic: 999

    SUMMARYParkinsonandapos s diseasePDis the second most prevalent neurodegenerative disorder after Alzheimerandapos s diseaseADaffecting more thanmillion people in the United StatesBecause age is the major risk factorthe prevalence of both diseases is steadily increasing as our population agesPD belongs to the group of protein misfolding neurodegenerative diseases that are due to the misfolding and ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  3. A Novel Chemokine Receptor Antagonist to Block Opioid Reinforcement, Relapse and Physical Dependence

    SBC: CREATIVE BIO-PEPTIDES INC            Topic: NIDA

    Project Summary Abstract This SBIR application is proposed in response to RFA DAthe HEAL Initiative on building technologies to stop the opioid crisisCreative Bio PeptidesIncis committed to providing effective and safe non opioid treatments for themillion Americans suffering daily pain and themillion who live with opioid dependency or addictionCurrent decades old addiction treatments like methadon ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  4. A single dose long-acting non-addictive polymer conjugate formulation of buprenorphine that provides immediate and prolonged analgesia for post-operative pain

    SBC: SERINA THERAPEUTICS INC            Topic: NINDS

    PAProject Summary Abstract SERis a long acting polymer pro drug of buprenorphine that is being developed to treat postoperative pain following major surgeries such as bunionectomyabdominoplastythoracotomy and knee and hip surgerySERhas no biological activity by itselfbut when administered in vivo by subcutaneous injection it enters the vascular compartment where a plasma esterasebutyrylcholinester ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  5. Osteoactivin Treatment for Accelerating Spinal Fusion in Osteoporosis

    SBC: GPN THERAPEUTICS, INC.            Topic: R

    Project Summary Abstract Overspinal fusions are performed annually in the US of whichundergo revision due to failure to fuseThe mean age for spinal fusion increased fromtoyears inIn patients older thanyearsthe frequency of osteoporosis is reported to bein women andin manThese patients experience substantial deterioration in the quality of lifeincreased dependency on othersand reduced lifespanVerte ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  6. User-driven Retrospectively Supervised Classification Updating (RESCU) system for robust upper limb prosthesis control

    SBC: INFINITE BIOMEDICAL TECHNOLOGIES, LLC            Topic: 105

    TBD

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  7. Development of Serious Games and Physical Activities Instructed by a Social Robot for Improving the Well-being of Elderly Individuals with Alzheimer's Disease and Dementia

    SBC: Dream Face Technologies, LLC            Topic: NIA

    The objective of the proposed direct Phase-II SBIR project is to develop and study and the effectiveness of Serious Games and physical Activities played/performed by elderly people with Alzheimer’s disease and AD- related Dementias in interaction with Ryan, our successfully piloted Socially Assistive Robot (SAR). Ryan is an intelligent conversational life-like social robot, designed to improve t ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  8. Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for relapse preventionin patients with Opioid Use (OUD)

    SBC: EVON MEDICS LLC            Topic: NIDA

    The Development and Evaluation of Computerized Chemosensory Based Orbitofrontal Cortex TrainingCBOTis an alternative strategy for relapse prevention in patients with Opioid UseOUDand other substance use disordersSUDOpioid and other forms of drug addiction can be defined as a failure to control drug seeking behaviorand reflect an exaggerated drive to consume drugsand or an inability to engage in ou ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  9. A Next Generation, Low Cost Tracking System for Healthcare Process Validation (2)

    SBC: GAN CORPORATION            Topic: 600

    PROJECT SUMMARY Significance: Americaandapos;s health care system remains challenged by tens of billions of dollars of fraud and inefficiencies. Lost and stolen equipment cost about $4,000 per hospital bed, increasing to $8,000 when expenses incurred from out-of-place equipment are added. In addition, a 2017 report estimates $95 billion was lost to fraud, waste, abuse, and other improper payments ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  10. Immunoactivating Peptide AXT201 in Combination with Anti-PD-1 Antibody for Triple-Negative Breast Cancer

    SBC: Asclepix Therapeutics, Inc.            Topic: 102

    Immunoactivating Peptide AXTin Combination with Anti PDAntibody for Triple Negative Breast CancerNiranjan BPandeyPh DPIJordan JGreen Ph DCo I Aleksander SPopelPh DPI of subcontract Project SummaryImmunotherapies are showing remarkable promise for treating various cancersAlthough many patients with different kinds of cancers are benefiting from these treatmentsthey appear to have hit a ceiling of b ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government